Literature DB >> 27818064

Autologous stem cell transplantation in a patient with sporadic late-onset nemaline myopathy and monoclonal gammopathy: First Moroccan experience.

Mohamed Reda Belkhribchia1, Ilias Tazi2, Nissrine Louhab3, Najib Kissani3, Lahoucine Mahmal2, Yann Pereon4.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27818064     DOI： 10.1016/j.lpm.2016.10.002

Source DB:  PubMed          Journal:  Presse Med        ISSN： 0755-4982            Impact factor:   1.228


× No keyword cloud information.
  5 in total

1.  Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort.

Authors:  Mauro Monforte; Guido Primiano; Gabriella Silvestri; Massimiliano Mirabella; Marco Luigetti; Cristina Cuccagna; Enzo Ricci; Serenella Servidei; Giorgio Tasca
Journal:  J Neurol       Date:  2018-01-22       Impact factor: 4.849

2.  Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy.

Authors:  Rouslan Kotchetkov; Anna Dyszkiewicz-Korpanty; Vishal Kukreti
Journal:  Bone Marrow Transplant       Date:  2018-01-24       Impact factor: 5.483

3.  Sporadic late-onset nemaline myopathy: a case report of a treatable cause of cardiac failure.

Authors:  Casmir Turnquist; Joanna C Grogono; Monika Hofer; Alex Pitcher
Journal:  Eur Heart J Case Rep       Date:  2020-12-22

4.  A case of sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance: long-term observation of neurological symptoms after autologous stem-cell transplantation.

Authors:  Takashi Ando; Takahiko Sato; Shingo Kurahashi; Yuka Kawaguchi; Yusuke Kagaya; Yukiyasu Ozawa; Satoko Hirano; Yoji Goto; Kazuo Mano; Satoshi Yokoi; Tomohiko Nakamura; Ayuka Murakami; Seiya Noda; Seigo Kimura; Jun Sone; Satoshi Kuru; Gen Sobue; Masahisa Katsuno
Journal:  Nagoya J Med Sci       Date:  2021-08       Impact factor: 1.131

5.  Inflammatory features in sporadic late-onset nemaline myopathy are independent from monoclonal gammopathy.

Authors:  Jantima Tanboon; Akinori Uruha; Yukie Arahata; Carsten Dittmayer; Leonille Schweizer; Hans-Hilmar Goebel; Ichizo Nishino; Werner Stenzel
Journal:  Brain Pathol       Date:  2021-05       Impact factor: 6.508
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.